SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-093298
Filing Date
2020-08-11
Accepted
2020-08-11 16:15:22
Documents
12
Period of Report
2020-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2027103-1_8ka.htm   iXBRL 8-K/A 26148
  Complete submission text file 0001104659-20-093298.txt   205023

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cara-20200604.xsd EX-101.SCH 3210
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20200604_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20200604_pre.xml EX-101.PRE 22726
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2027103-1_8ka_htm.xml XML 4404
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36279 | Film No.: 201092595
SIC: 2834 Pharmaceutical Preparations